ZURAMPIC (AstraZeneca Pharmaceuticals LP)


Welcome to the PulseAid listing for the ZURAMPIC drug offered from AstraZeneca Pharmaceuticals LP. This Urate Transporter 1 Inhibitor [EPC],Urate Transporter 1 Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AstraZeneca Pharmaceuticals LP
NON-PROPRIETARY NAME: lesinurad
SUBSTANCE NAME: LESINURAD
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Urate Transporter 1 Inhibitor [EPC],Urate Transporter 1 Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-08-11
END MARKETING DATE: 0000-00-00


ZURAMPIC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZURAMPIC from AstraZeneca Pharmaceuticals LP
LABELER NAME: AstraZeneca Pharmaceuticals LP
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2016-08-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0310-1475_fbdd2500-f1bb-488b-8cfa-fc16148771d3
PRODUCT NDC: 0310-1475
APPLICATION NUMBER: NDA207988

Other LESINURAD Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPZURAMPIC
Ironwood Pharmaceuticals, Inc.Zurampic